6. Parkinson disease Clinical trials / Disease details

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100050538	2021-09-01	2021-08-28	Clinical study of Ganoderma lucidum extract in the treatment of motor and non motor symptoms in patients with early PD	Clinical study of Ganoderma lucidum extract in the treatment of motor and non motor symptoms in patients with early PD	Parkinson's disease	Experimental group:Reishi Mushroom Extract Treatment;Control group:None;	Xuanwu Hospital of Capital Medical University	NULL	Recruiting	18	80	Both	Experimental group:30;Control group:30;		China
2	NCT03594656 (ClinicalTrials.gov)	July 15, 2018	11/7/2018	Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease	Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial	Parkinson Disease	Drug: Ganoderma;Drug: Placebos	Xuanwu Hospital, Beijing	NULL	Recruiting	30 Years	80 Years	All	288	Phase 3	China
3	NCT00224263 (ClinicalTrials.gov)	September 2005	20/9/2005	Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease	A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease Receiving Stable L-dopa/DCI	Parkinson's Disease	Drug: Lingzhi (Ganoderma)	Xuanwu Hospital, Beijing	NULL	Completed	30 Years	80 Years	Both	360	Phase 2	China